Achiko Logo cropped.jpg
2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders Adopt All Proposals
December 20, 2022 15:03 ET | Achiko AG
ZURICH, Switzerland, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) held its Annual General Meeting today at 10:00 CET in Zurich....
Achiko Logo cropped.jpg
Achiko AG Announces Corporate Update Webcast
November 16, 2022 10:38 ET | Achiko AG
ZURICH, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare technology company that is developing new...
Achiko Logo cropped.jpg
Achiko AG Commences Commercial Deliveries in Indonesia
November 14, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud to...
Achiko Logo cropped.jpg
Achiko AG Production and Company Update
November 02, 2022 07:34 ET | Achiko AG
Completing Production Pilot for Generation 2 of AptameX™ as a Precursor to Mass Commercial ProductionExpect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of...
Achiko Logo cropped.jpg
Achiko AG Appoints New Chief Financial Officer
October 07, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare...
Achiko Logo cropped.jpg
Achiko AG – Investor Briefing
July 07, 2022 15:22 ET | Achiko AG
ZURICH, Switzerland, July 07, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF, SIX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a...
Achiko Logo cropped.jpg
Achiko AG Announces Annual Results for the Year Ended December 31, 2021
June 26, 2022 19:30 ET | Achiko AG
ZURICH, Switzerland, June 26, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended December...
Dyadic Logo Current.jpg
Dyadic to Participate in Three Upcoming Industry Events
June 09, 2022 09:09 ET | Dyadic International, Inc.
JUPITER, Fla., June 09, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and...
Achiko Logo cropped.jpg
Achiko Secures $1.3 Million Financing with Strategic Investors Buranto AG and Negma Group
May 25, 2022 07:30 ET | Achiko AG
Buranto AG Provided a USD$260,000 (CHF 250,000) Loan Facility and Existing Strategic Investor Negma Group Provided a USD$1.04 Million (CHF 1.0 Million) Loan FacilityDerek Brandt, Co-owner of Buranto...
Achiko Logo cropped.jpg
Achiko AG Obtains CE Mark for AptameX™ Covid-19 Rapid Test
May 17, 2022 07:30 ET | Achiko AG
Registered AptameX and Has Obtained a CE Mark, Allowing the Product to Be Sold in 27 Countries in the EUAptameX Has Unique Performance Advantages Over Other Rapid Tests Through its Use of DNA...